Home / Life Sciences

Legal News

EFPIA welcomes use of aggregate data to help manage coronavirus (COVID-19) risks

Copyright © 2025 LexisNexis

Published on: 20 May 2020

Published by LNB News

LNB News 20/05/2020

Document Information

Issue Date: 20 May 2020

Published Date: 20 May 2020

Jurisdiction(s): United Kingdom

Article summary

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has released a statement following a call with EU Commissioner Kyriakides on the subject of Europe’s continued fight against coronavirus (COVID-19). The statement welcomes the efforts of the European Medicines Agency and the European Centre for Disease Control (ECDC) in using forecasting data from the ECDC and data held in national repositories in accordance with the EU Falsified Medicines Directive to help plan and manage the allocation of medicines to prevent any potential shortages.

Popular documents

What is the difference between an appeal and a review?

What is the difference between an appeal and a review?What is an appeal?An appeal in insolvency proceedings is no different to an appeal in normal litigation. An appeal will be allowed only if the appeal court is satisfied that the decision of the lower court was 'wrong' or 'unjust because of a

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of